Glenmark Pharmaceuticals receives six observations after US FDA inspection of Goa plant

Shares of Glenmark Pharmaceuticals Ltd ended at ₹2,204.90, down by ₹18.70, or 0.86%, on the BSE.

Leave a Reply

Your email address will not be published. Required fields are marked *